198 related articles for article (PubMed ID: 11434124)
1. [Arm morbidity after axillary dissection for breast cancer].
Stahlberg CI; Jørgensen T
Ugeskr Laeger; 2001 Jun; 163(24):3356-9. PubMed ID: 11434124
[TBL] [Abstract][Full Text] [Related]
2. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
3. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
4. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.
Voogd AC; Ververs JM; Vingerhoets AJ; Roumen RM; Coebergh JW; Crommelin MA
Br J Surg; 2003 Jan; 90(1):76-81. PubMed ID: 12520579
[TBL] [Abstract][Full Text] [Related]
5. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
6. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
Leidenius M; Leivonen M; Vironen J; von Smitten K
J Surg Oncol; 2005 Oct; 92(1):23-31. PubMed ID: 16180231
[TBL] [Abstract][Full Text] [Related]
7. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
8. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
9. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
10. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
11. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study.
Sagen A; Kåresen R; Sandvik L; Risberg MA
Acta Oncol; 2009; 48(8):1111-8. PubMed ID: 19863218
[TBL] [Abstract][Full Text] [Related]
12. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
[TBL] [Abstract][Full Text] [Related]
13. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
[TBL] [Abstract][Full Text] [Related]
14. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
[TBL] [Abstract][Full Text] [Related]
16. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
17. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of the morbidity of axillary clearance for breast cancer.
Duff M; Hill AD; McGreal G; Walsh S; McDermott EW; O'Higgins NJ
Br J Surg; 2001 Jan; 88(1):114-7. PubMed ID: 11136322
[TBL] [Abstract][Full Text] [Related]
19. Impact of axillary level I and II lymphnode dissection on the therapy of stage I and II breast cancer.
Tocchi A; Mazzoni G; Bettelli E; Miccini M; Giuliani A; Cassini D
Panminerva Med; 2001 Jun; 43(2):103-7. PubMed ID: 11449180
[TBL] [Abstract][Full Text] [Related]
20. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]